Teva Pharmaceutical Industries Ltd (ADR) (N:TEVA)

Business Focus: Pharmaceuticals

INK Ultra Money Free

INK Ultra Money Premium

Get a Canadian Insider Club Ultra subscription for

  • Insider filing email alerts
  • Access to premium INK Research reports
  • Full access to weekly North America Top filer reports
  • Ad-free browsing
  • INK Ultra Money premium content

(already an Ultra member? Please log into your account for access)

Latest 10 SEC filings (by transaction date) for TEVA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 16th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 3/19 Dec 2/19 Fridriksdottir Hafrun Direct Ownership Ordinary Shares S - Open market or private sale -4,310 $10.49
Dec 3/19 Nov 30/19 Fridriksdottir Hafrun Direct Ownership Restricted Share Units M - Exercise or conversion exempt under rule 16b-3 -8,133  
Dec 3/19 Nov 30/19 Fridriksdottir Hafrun Direct Ownership Ordinary Shares M - Exercise or conversion exempt under rule 16b-3 8,133  
Nov 6/19 Nov 5/19 McClellan Michael James Direct Ownership Restricted Share Units M - Exercise or conversion exempt under rule 16b-3 -695  
Nov 6/19 Nov 5/19 McClellan Michael James Direct Ownership Ordinary Shares S - Open market or private sale -242 $8.83
Nov 6/19 Nov 5/19 McClellan Michael James Direct Ownership Ordinary Shares M - Exercise or conversion exempt under rule 16b-3 695  
Nov 5/19 Nov 3/19 Schultz Kare Direct Ownership Restricted Share Units M - Exercise or conversion exempt under rule 16b-3 -63,613  
Nov 5/19 Nov 3/19 Schultz Kare Direct Ownership Ordinary Shares M - Exercise or conversion exempt under rule 16b-3 63,613  
Oct 15/19 Oct 15/19 Drape Eric Direct Ownership Restricted Share Units Form 3 : Initial Statement of Beneficial Ownership of Securities    
Oct 15/19 Oct 15/19 Drape Eric Direct Ownership Stock Options (right to buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for TEVA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 16th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 3/19 Nov 30/19 Fridriksdottir Hafrun Direct Ownership Restricted Share Units M - Exercise or conversion exempt under rule 16b-3 -8,133  
Dec 3/19 Dec 2/19 Fridriksdottir Hafrun Direct Ownership Ordinary Shares S - Open market or private sale -4,310 $10.49
Dec 3/19 Nov 30/19 Fridriksdottir Hafrun Direct Ownership Ordinary Shares M - Exercise or conversion exempt under rule 16b-3 8,133  
Nov 6/19 Nov 5/19 McClellan Michael James Direct Ownership Restricted Share Units M - Exercise or conversion exempt under rule 16b-3 -695  
Nov 6/19 Nov 5/19 McClellan Michael James Direct Ownership Ordinary Shares S - Open market or private sale -242 $8.83
Nov 6/19 Nov 5/19 McClellan Michael James Direct Ownership Ordinary Shares M - Exercise or conversion exempt under rule 16b-3 695  
Nov 5/19 Nov 3/19 Schultz Kare Direct Ownership Restricted Share Units M - Exercise or conversion exempt under rule 16b-3 -63,613  
Nov 5/19 Nov 3/19 Schultz Kare Direct Ownership Ordinary Shares M - Exercise or conversion exempt under rule 16b-3 63,613  
Oct 15/19 Oct 15/19 Drape Eric Direct Ownership Restricted Share Units Form 3 : Initial Statement of Beneficial Ownership of Securities    
Oct 15/19 Oct 15/19 Drape Eric Direct Ownership Stock Options (right to buy) Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $TEVA

Competitors

Competitors with Recent Insider Filings
Merck & Co. (N:MRK)
Odonate Therapeutics (OQ:ODT)
Horizon Therapeutics PLC (OQ:HZNP)